Élodie Vauléon

4.2k total citations
60 papers, 1.8k citations indexed

About

Élodie Vauléon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Élodie Vauléon has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 18 papers in Genetics. Recurrent topics in Élodie Vauléon's work include Glioma Diagnosis and Treatment (18 papers), Brain Metastases and Treatment (12 papers) and Head and Neck Cancer Studies (9 papers). Élodie Vauléon is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Brain Metastases and Treatment (12 papers) and Head and Neck Cancer Studies (9 papers). Élodie Vauléon collaborates with scholars based in France, Switzerland and United States. Élodie Vauléon's co-authors include Tony Avril, Éric Chevet, Véronique Quillien, Jean Mosser, Abderrahmane Hamlat, Jean‐Luc Raoul, Stéphan Saïkali, Éveline Boucher, Julien Edeline and Amandine Etcheverry and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Élodie Vauléon

60 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Élodie Vauléon France 24 596 522 449 414 302 60 1.8k
Kanako C. Hatanaka Japan 24 613 1.0× 564 1.1× 145 0.3× 409 1.0× 317 1.0× 143 2.0k
Iacopo Petrini Italy 27 1.0k 1.7× 884 1.7× 214 0.5× 723 1.7× 193 0.6× 91 2.5k
Nathalie A. Lokker United States 20 468 0.8× 1.1k 2.0× 328 0.7× 164 0.4× 293 1.0× 29 2.1k
Ann Cleverly United States 25 1.5k 2.5× 1.3k 2.5× 259 0.6× 333 0.8× 530 1.8× 54 2.6k
Christopher L. Tinkle United States 17 654 1.1× 702 1.3× 299 0.7× 264 0.6× 425 1.4× 58 1.9k
Kurt Grünewald Austria 18 669 1.1× 902 1.7× 282 0.6× 163 0.4× 200 0.7× 29 2.2k
Michael Lahn United States 23 1.1k 1.9× 1.3k 2.5× 203 0.5× 264 0.6× 369 1.2× 42 2.2k
Rebecca Senetta Italy 21 1.1k 1.8× 717 1.4× 237 0.5× 308 0.7× 228 0.8× 92 2.0k
Takafumi Sangai Japan 26 979 1.6× 877 1.7× 267 0.6× 317 0.8× 350 1.2× 78 2.1k
Vassiliki Kotoula Greece 27 1.2k 2.0× 1.2k 2.4× 193 0.4× 419 1.0× 324 1.1× 125 2.6k

Countries citing papers authored by Élodie Vauléon

Since Specialization
Citations

This map shows the geographic impact of Élodie Vauléon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Élodie Vauléon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Élodie Vauléon more than expected).

Fields of papers citing papers by Élodie Vauléon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Élodie Vauléon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Élodie Vauléon. The network helps show where Élodie Vauléon may publish in the future.

Co-authorship network of co-authors of Élodie Vauléon

This figure shows the co-authorship network connecting the top 25 collaborators of Élodie Vauléon. A scholar is included among the top collaborators of Élodie Vauléon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Élodie Vauléon. Élodie Vauléon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edeline, Julien, et al.. (2023). Evolution of parenteral nutrition practices in a comprehensive cancer center: Comparative audits. Bulletin du Cancer. 110(7-8). 758–767. 2 indexed citations
2.
Dufresne, Armelle, Olivier Huillard, Cécile Dalban, et al.. (2022). 465P Larotracking: Real-life study of locally advanced/metastatic solid tumor treated with larotrectinib in French expanded access program. Annals of Oncology. 33. S753–S753. 2 indexed citations
3.
Klein, Martin, Martin J. van den Bent, Jacoline E. C. Bromberg, et al.. (2020). Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033. Neuro-Oncology. 23(5). 803–811. 29 indexed citations
4.
Even, Caroline, Amaury Daste, Jérôme Fayette, et al.. (2020). 917MO TOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis. Annals of Oncology. 31. S662–S662. 1 indexed citations
5.
Lelièvre, Bénédicte, et al.. (2019). Rethinking Alkylating(-Like) Agents for Solid Tumor Management. Trends in Pharmacological Sciences. 40(5). 342–357. 38 indexed citations
6.
7.
Avril, Tony, Amandine Etcheverry, Raphaël Pineau, et al.. (2017). CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma. Clinical Cancer Research. 23(23). 7360–7374. 34 indexed citations
8.
Quillien, Véronique, Audrey Lavenu, François Ducray, et al.. (2017). Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients. Cancer Biomarkers. 20(4). 435–441. 14 indexed citations
9.
10.
Avril, Tony, Élodie Vauléon, & Éric Chevet. (2017). Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis. 6(8). e373–e373. 215 indexed citations
11.
Bonnet, Charlotte, Laure Thomas, Dimitri Psimaras, et al.. (2016). Characteristics of gliomas in patients with somatic IDH mosaicism. Acta Neuropathologica Communications. 4(1). 31–31. 26 indexed citations
12.
Lebellec, Loïc, Axel Le Cesne, Nicolas Penel, et al.. (2016). Molecular targeted therapies (MTT) in advanced chordoma (AC) patients (pts).. Journal of Clinical Oncology. 34(15_suppl). 11020–11020. 1 indexed citations
13.
Pouessel, Damien, Sylvie Chevret, Frédéric Rolland, et al.. (2015). Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?. European Journal of Cancer. 54. 69–74. 11 indexed citations
14.
Tauziède‐Espariat, Arnault, A. Maues de Paula, Mélanie Pagès, et al.. (2015). Primary Leptomeningeal Gliomatosis in Children and Adults. Neurosurgery. 78(3). 343–352. 9 indexed citations
15.
Etcheverry, Amandine, Marc Aubry, Ahmed Idbaïh, et al.. (2014). DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide. PLoS ONE. 9(9). e104455–e104455. 19 indexed citations
16.
Vauléon, Élodie, Tony Avril, Abderrahmane Hamlat, et al.. (2012). Immune genes are associated with human glioblastoma pathology and patient survival. BMC Medical Genomics. 5(1). 41–41. 42 indexed citations
17.
18.
Etcheverry, Amandine, Marc Aubry, Marie de Tayrac, et al.. (2010). DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics. 11(1). 701–701. 179 indexed citations
19.
Jouneau, S., Élodie Vauléon, Sylvie Caulet-Maugendre, et al.. (2010). 131I-Labeled Lipiodol-Induced Interstitial Pneumonia. CHEST Journal. 139(6). 1463–1469. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kanako C. Hatanaka Breakdown of academic impact, for papers by Iacopo Petrini Breakdown of academic impact, for papers by Nathalie A. Lokker Breakdown of academic impact, for papers by Ann Cleverly Breakdown of academic impact, for papers by Christopher L. Tinkle Breakdown of academic impact, for papers by Kurt Grünewald Breakdown of academic impact, for papers by Michael Lahn Breakdown of academic impact, for papers by Rebecca Senetta Breakdown of academic impact, for papers by Takafumi Sangai Breakdown of academic impact, for papers by Vassiliki Kotoula
Rankless by CCL
2026